SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Enovis Corp. – ‘10-Q’ for 4/2/21 – ‘EX-31.01’

On:  Thursday, 4/29/21, at 6:28am ET   ·   For:  4/2/21   ·   Accession #:  1420800-21-16   ·   File #:  1-34045

Previous ‘10-Q’:  ‘10-Q’ on 10/29/20 for 10/2/20   ·   Next:  ‘10-Q’ on 7/28/21 for 7/2/21   ·   Latest:  ‘10-Q’ on 11/7/23 for 9/29/23   ·   5 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 4/29/21  Colfax Corp.                      10-Q        4/02/21   77:6.1M

Quarterly Report   —   Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    721K 
 2: EX-31.01    Certification -- §302 - SOA'02                      HTML     27K 
 3: EX-31.02    Certification -- §302 - SOA'02                      HTML     27K 
 4: EX-32.01    Certification -- §906 - SOA'02                      HTML     21K 
 5: EX-32.02    Certification -- §906 - SOA'02                      HTML     21K 
12: R1          Cover Page                                          HTML     77K 
13: R2          Condensed Consolidated Statements of Income         HTML     86K 
14: R3          Condensed Consolidated Statements of Comprehensive  HTML     49K 
                Income (Loss)                                                    
15: R4          Condensed Consolidated Statements of Comprehensive  HTML     27K 
                Income (Loss) [Parenthetical]                                    
16: R5          Condensed Consolidated Balance Sheets               HTML     93K 
17: R6          Condensed Consolidated Balance Sheets               HTML     31K 
                [Parenthetical]                                                  
18: R7          Condensed Consolidated Statement of Equity          HTML     63K 
19: R8          Condensed Consolidated Statement of Equity          HTML     22K 
                Statement of Stockholders' Equity [Parenthetical]                
20: R9          Condensed Consolidated Statements of Cash Flows     HTML     84K 
21: R10         General                                             HTML     29K 
22: R11         Recently Issued Accounting Pronouncements           HTML     26K 
23: R12         Discontinued Operations                             HTML     24K 
24: R13         Acquisitions Acquisitions (Notes)                   HTML     23K 
25: R14         Revenue (Notes)                                     HTML     47K 
26: R15         Net Income Per Share (Text Block)                   HTML     39K 
27: R16         Income Taxes                                        HTML     23K 
28: R17         Equity                                              HTML     73K 
29: R18         Inventories, Net (Text Block)                       HTML     30K 
30: R19         Debt                                                HTML     41K 
31: R20         Accrued Liabilities (Text Block)                    HTML     81K 
32: R21         Financial Instruments and Fair Value Measurements   HTML     79K 
33: R22         Commitments and Contingencies (Text Block)          HTML     41K 
34: R23         Segment Information (Text Block)                    HTML     52K 
35: R24         Subsequent Events (Notes)                           HTML     22K 
36: R25         Recently Issued Accounting Pronouncements           HTML     32K 
                (Policies)                                                       
37: R26         Recently Issued Accounting Pronouncements (Tables)  HTML     27K 
38: R27         Revenue (Tables)                                    HTML     46K 
39: R28         Net Income Per Share (Tables)                       HTML     38K 
40: R29         Equity (Tables)                                     HTML     67K 
41: R30         Inventories, Net (Tables)                           HTML     31K 
42: R31         Debt (Tables)                                       HTML     32K 
43: R32         Accrued Liabilities (Tables)                        HTML     86K 
44: R33         Financial Instruments and Fair Value Measurements   HTML     89K 
                (Tables)                                                         
45: R34         Commitments and Contingencies (Tables)              HTML     39K 
46: R35         Segment Information (Tables)                        HTML     50K 
47: R36         General General (Details)                           HTML     23K 
48: R37         Discontinued Operations - Narratives (Details)      HTML     32K 
49: R38         Acquisitions - Narrative (Details)                  HTML     38K 
50: R39         Revenue - Disaggregation of Revenue (Details)       HTML     31K 
51: R40         Revenue - Narrative (Details)                       HTML     28K 
52: R41         Revenue - Allowance for Credit Loss Rollforward     HTML     31K 
                (Details)                                                        
53: R42         Net Income Per Share (Details)                      HTML     41K 
54: R43         Net Income Per Share (Details Textual)              HTML     28K 
55: R44         Income Taxes (Details)                              HTML     28K 
56: R45         Equity Textual (Details)                            HTML     49K 
57: R46         Equity - AOCI Components (Details)                  HTML     57K 
58: R47         Inventories, Net (Details)                          HTML     33K 
59: R48         Debt - Components (Details)                         HTML     37K 
60: R49         Debt -Textual (Details)                             HTML     85K 
61: R50         Accrued Liabilities Chart (Details)                 HTML     46K 
62: R51         Warranty Liability Rollforward (Details)            HTML     34K 
63: R52         Restructuring Rollforward (Details)                 HTML     51K 
64: R53         Accrued Liabilities (Details Textual)               HTML     31K 
65: R54         Financial Instruments and Fair Value Measurements   HTML     21K 
                (Details)                                                        
66: R55         Financial Instruments and Fair Value Measurements-  HTML     41K 
                Fair Value Hierarchy (Details)                                   
67: R56         Financial Instruments and Fair Value Measurements   HTML     22K 
                - Foreign Currency Contracts Notional Values                     
                (Details)                                                        
68: R57         Financial Instruments and Fair Value Measurements   HTML     30K 
                - Gain (Loss) On Derivative Instruments (Details)                
69: R58         Financial Instruments and Fair Value Measurements   HTML     29K 
                - Schedule of Cash and Cash Equivalents and                      
                Restricted Cash (Details)                                        
70: R59         Claims Rollforward (Details)                        HTML     26K 
71: R60         Asbestos Litigation (Details 1)                     HTML     26K 
72: R61         Segment Information (Details)                       HTML     43K 
73: R62         Subsequent Events (Details)                         HTML     41K 
75: XML         IDEA XML File -- Filing Summary                      XML    135K 
11: XML         XBRL Instance -- cfx-20210402_htm                    XML   1.47M 
74: EXCEL       IDEA Workbook of Financial Reports                  XLSX     82K 
 7: EX-101.CAL  XBRL Calculations -- cfx-20210402_cal                XML    195K 
 8: EX-101.DEF  XBRL Definitions -- cfx-20210402_def                 XML    435K 
 9: EX-101.LAB  XBRL Labels -- cfx-20210402_lab                      XML   1.27M 
10: EX-101.PRE  XBRL Presentations -- cfx-20210402_pre               XML    715K 
 6: EX-101.SCH  XBRL Schema -- cfx-20210402                          XSD    151K 
76: JSON        XBRL Instance as JSON Data -- MetaLinks              290±   418K 
77: ZIP         XBRL Zipped Folder -- 0001420800-21-000016-xbrl      Zip    236K 


‘EX-31.01’   —   Certification — §302 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  

Exhibit 31.01
CERTIFICATIONS
I, Matthew L. Trerotola, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Colfax Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 (a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 (b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 (c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 (d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
 (a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
 (b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Dated: April 29, 2021
Matthew L. Trerotola
President and Chief Executive Officer
(Principal Executive Officer)


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:4/29/218-K
For Period end:4/2/21
 List all Filings 


2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/30/21  Enovis Corp.                      424B7                  1:341K                                   Donnelley … Solutions/FA
 7/28/21  Enovis Corp.                      424B7                  1:338K                                   Donnelley … Solutions/FA


3 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/05/21  Enovis Corp.                      8-K:5,9     3/03/21   18:468K                                   Donnelley … Solutions/FA
 7/23/15  Enovis Corp.                      10-Q        6/26/15   72:7M
 1/30/12  Enovis Corp.                      8-K:1,3,9   1/24/12    7:1M                                     Skadden/FA
Top
Filing Submission 0001420800-21-000016   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 12:31:14.1pm ET